|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Current assets: | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Marketable securities | |||||||||||||||||
| Prepaid expenses and other assets | |||||||||||||||||
| Total current assets: | |||||||||||||||||
| Property and equipment, net | |||||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||||
| Marketable securities | |||||||||||||||||
| Restricted cash | |||||||||||||||||
| Other long-term assets | |||||||||||||||||
| Total assets | |||||||||||||||||
| Liabilities and stockholders' equity | |||||||||||||||||
| Current liabilities: | |||||||||||||||||
| Accounts payable | |||||||||||||||||
| Accrued expenses | |||||||||||||||||
| Current portion of operating lease liabilities | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Operating lease liabilities, net of current portion | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Stockholders' equity: | |||||||||||||||||
| Series A non-voting convertible preferred stock, $0.0001 par value; 100,000,000 shares authorized at September 30, 2025 and December 31,2024;70,601 shares issued and outstanding at September 30, 2025 and December 31, 2024 | |||||||||||||||||
| Common stock, $0.0001 par value; 900,000,000 shares authorized at September 30, 2025 and December 31, 2024; 71,336,958 and 71,130,054 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Accumulated other comprehensive income | |||||||||||||||||
| Accumulated deficit | |||||||||||||||||
| Total stockholders' equity | |||||||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||||||
Loading...
